Publicacións (40) Publicacións de RUBÉN MARTÍN ESCOLANO

2024

  1. Plasma metabolomic profile is near-normal in people with HIV on long-term suppressive antiretroviral therapy

    Frontiers in Cellular and Infection Microbiology, Vol. 14

  2. Sustained Long-Term Decline in Anti-HCV Neutralizing Antibodies in HIV/HCV-Coinfected Patients Five Years after HCV Therapy: A Retrospective Study

    Pharmaceuticals, Vol. 17, Núm. 9

2023

  1. Identification of Aryl Polyamines Derivatives as Anti-Trypanosoma cruzi Agents Targeting Iron Superoxide Dismutase †

    Pharmaceutics, Vol. 15, Núm. 1

  2. Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk

    Immunity and Ageing, Vol. 20, Núm. 1

  3. Predictive plasma biomarkers of long-term increase in hepatic steatosis index after HCV eradication in HIV/HCV-coinfected patients

    Biomedicine and Pharmacotherapy, Vol. 164

  4. Resistance of Blastocystis to chlorine and hydrogen peroxide

    Parasitology Research, Vol. 122, Núm. 1, pp. 167-176

2022

  1. 5-Nitroindazole derivatives as potential therapeutic alternatives against Acanthamoeba castellanii

    Acta Tropica, Vol. 232

  2. A Zn2+-triggered two-step mechanism of CLIC1 membrane insertion and activation into chloride channels

    Journal of Cell Science, Vol. 135, Núm. 15

  3. An Updated View of the Trypanosoma cruzi Life Cycle: Intervention Points for an Effective Treatment

    ACS infectious diseases, Vol. 8, Núm. 6, pp. 1107-1115

  4. Biological characteristics of the Trypanosoma cruzi Arequipa strain make it a good model for Chagas disease drug discovery

    Acta Tropica, Vol. 236

  5. Localization and functional characterization of the alternative oxidase in Naegleria

    Journal of Eukaryotic Microbiology, Vol. 69, Núm. 4

2021

  1. Heterocyclic Diamines with Leishmanicidal Activity

    ACS Infectious Diseases, Vol. 7, Núm. 12, pp. 3168-3181

  2. In vitro anti-Acanthamoeba activity of flavonoid glycosides isolated from Delphinium gracile, D. staphisagria, Consolida oliveriana and Aconitum napellus

    Parasitology, Vol. 148, Núm. 11, pp. 1392-1400

  3. Library of selenocyanate and diselenide derivatives as in vivo antichagasic compounds targeting trypanosoma cruzi mitochondrion

    Pharmaceuticals, Vol. 14, Núm. 5

  4. Repurposing in vitro approaches for screening anti-parasitic drugs against the brain-eating amoeba Naegleria fowleri

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 17, pp. 204-212

  5. Selenium Derivatives as Promising Therapy for Chagas Disease: In Vitro and in Vivo Studies

    ACS Infectious Diseases, Vol. 7, Núm. 6, pp. 1727-1738

2020

  1. Assessing the effectiveness of AS-48 in experimental mice models of Chagas' disease

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 6, pp. 1537-1545

  2. Chagas Disease: Current View of an Ancient and Global Chemotherapy Challenge

    ACS Infectious Diseases, Vol. 6, Núm. 11, pp. 2830-2843

  3. In Vivo Biological Evaluation of a Synthetic Royleanone Derivative as a Promising Fast-Acting Trypanocidal Agent by Inducing Mitochondrial-Dependent Necrosis

    Journal of Natural Products, Vol. 83, Núm. 12, pp. 3571-3583

  4. In vitro evaluation of leishmanicidal properties of a new family of monodimensional coordination polymers based on diclofenac ligand

    Polyhedron, Vol. 184